Organs

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease

Retrieved on: 
Wednesday, April 28, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Genetics, Clinical trials, Liver, Organs, Hepatology

We believe the pharmacodynamic effect in alpha-1 patients is clear and consistent.

Key Points: 
  • We believe the pharmacodynamic effect in alpha-1 patients is clear and consistent.
  • The results from 24 and 48 weeks of treatment also indicate that when production of the Z-AAT protein is inhibited, the liver has the ability to clear the accumulated mutant protein and begin the fibrosis regression process earlier and more efficiently than we anticipated, even in patients with severe liver disease.
  • Treated participants will also be offered the opportunity to continue treatment in an open-label extension (OLE).
  • We assume no obligation to update or revise forward-looking statements to reflect new events or circumstances.\n'

Selfies as Skin Saviors - IDTechEx Investigates Skin Sensor Technology

Retrieved on: 
Tuesday, April 27, 2021
Organ systems, Branches of biology, Anatomy, Acneiform eruptions, Organs, Puberty, Ageing, Skin, Wrinkle, Acne

New skin sensor technology could cut through this noise.\nThe constant improvements to the front-facing cameras on smartphones, as well as developments in processing power and machine learning, have led to the commercialization of smartphone and selfie-based skin analysis tools.

Key Points: 
  • New skin sensor technology could cut through this noise.\nThe constant improvements to the front-facing cameras on smartphones, as well as developments in processing power and machine learning, have led to the commercialization of smartphone and selfie-based skin analysis tools.
  • Broadly, the parameters are: skin hydration, topographical features, sebum, color, and skin elasticity/firmness.\nWrinkles and lines are folds and valleys in the skin wrinkles are substantial features, greater in size and depth, than fine lines.\nWrinkles are a feature of aging skin.
  • Acne is a common skin condition, and among its many causes, increased sebum secretion is the major factor.\nChowis Technology has anai-based technology called mySkin Choice.
  • Elastic skin tends to have a round shape, while aged skin has pores that are tiled downward as ovals.

Selfies as Skin Saviors - IDTechEx Investigates Skin Sensor Technology

Retrieved on: 
Tuesday, April 27, 2021
Organ systems, Branches of biology, Anatomy, Acneiform eruptions, Organs, Puberty, Ageing, Skin, Wrinkle, Acne

New skin sensor technology could cut through this noise.\nThe constant improvements to the front-facing cameras on smartphones, as well as developments in processing power and machine learning, have led to the commercialization of smartphone and selfie-based skin analysis tools.

Key Points: 
  • New skin sensor technology could cut through this noise.\nThe constant improvements to the front-facing cameras on smartphones, as well as developments in processing power and machine learning, have led to the commercialization of smartphone and selfie-based skin analysis tools.
  • Broadly, the parameters are: skin hydration, topographical features, sebum, color, and skin elasticity/firmness.\nWrinkles and lines are folds and valleys in the skin wrinkles are substantial features, greater in size and depth, than fine lines.\nWrinkles are a feature of aging skin.
  • Acne is a common skin condition, and among its many causes, increased sebum secretion is the major factor.\nChowis Technology has anai-based technology called mySkin Choice.
  • Elastic skin tends to have a round shape, while aged skin has pores that are tiled downward as ovals.

Liver Disease Diagnostics Market to Surpass $50.61 Billion By 2028 | Exclusive Study by Polaris Market Research

Retrieved on: 
Tuesday, April 27, 2021
Liver, Organs

b"NEW YORK, April 27, 2021 /PRNewswire/ -- The liver disease diagnostics market is projected to cross USD 50.61 billion by 2028accordingto a new study conducted by Polaris Market Research.

Key Points: 
  • b"NEW YORK, April 27, 2021 /PRNewswire/ -- The liver disease diagnostics market is projected to cross USD 50.61 billion by 2028accordingto a new study conducted by Polaris Market Research.
  • Growing prevalence of life-related disorders creating a huge burden on liver diseases, thereby augmenting the growth of the market.
  • Furthermore, an increase in research initiatives and heavy funding by industry participants to improve their product offerings is further driving the market growth.
  • Request for customization: https://www.polarismarketresearch.com/industry-analysis/liver-disease-di...\nPolaris Market research has segmented the liver disease diagnostics market report on the basis of diagnosis technique, type, and region:\nLiver Disease Diagnostics, Diagnosis Technique Outlook (Revenue USD Million, 2016 2028)\n"

ENZYVANT Resubmits Biologics Licensing Application (BLA) to FDA for RVT-802 for Pediatric Congenital Athymia

Retrieved on: 
Tuesday, April 27, 2021
Medical specialties, Branches of biology, Anatomy, Immune system, Lymphatic system, Mammal anatomy, Organs, Thymus, Immunodeficiency, Food and Drug Administration, Autoimmunity

Enzyvant has been working since that time to address each of the FDA requests.

Key Points: 
  • Enzyvant has been working since that time to address each of the FDA requests.
  • With only supportive care, patients with congenital athymia typically die from infections or autoimmune manifestations by age two or three.
  • Investigational RVT-802 is cultured human thymus tissue for the treatment of pediatric congenital athymia and is implanted in a single surgery.
  • Enzyvant\xe2\x80\x99s lead asset is the investigational tissue-based regenerative therapy, RVT-802, for congenital athymia, an ultra-rare and life-threatening pediatric immunodeficiency.

Heartiversaries Earn a Spot on the Celebration Calendar

Retrieved on: 
Friday, April 23, 2021
Heart, Organs, The Ultimate Warrior, Professional wrestling in the United States

"After speaking with Sonja, it became very clear that Heartiversaries are a milestone that millions of people around the world celebrate, yet it is not a commercially recognized Day.

Key Points: 
  • "After speaking with Sonja, it became very clear that Heartiversaries are a milestone that millions of people around the world celebrate, yet it is not a commercially recognized Day.
  • We\'re changing that -- these heart warriors have been given a second chance at life!
  • "\nA "Heartiversary" is the anniversary of a cardiac surgery and recognizes each year following that another year has passed since the heart warrior was given a second chance to live.
  • Prices range from $9.99 to $34.99 and are available to order here on the company website https://www.bigdotofhappiness.com .

Keto-Friendly Support for the Liver and Kidneys

Retrieved on: 
Thursday, April 22, 2021
Mexican cuisine, Philippine cuisine, Food and drink, Liver, Organs, Dietary supplement, Kidney, Cuisine

b"FORT LAUDERDALE, Fla., April 22, 2021 /PRNewswire/ --Health and Wellness brand Suraksha Naturals has created two products distinctly tailored to supporting liver and kidney health.

Key Points: 
  • b"FORT LAUDERDALE, Fla., April 22, 2021 /PRNewswire/ --Health and Wellness brand Suraksha Naturals has created two products distinctly tailored to supporting liver and kidney health.
  • Ketoveyda products aim to address these concerns by supplementing the diet with critical missing nutrients.\nFor instance, studies have shown that eating keto can lead to elevated liver enzymes as well as additional stress on kidneys.
  • Suraksha Naturals has answered these concerns with two products, Ketoveyda Herbal Liver Care Supplement and its Ketoveyda Herbal Kidney Care Supplement, respectively.\nKetoveyda's Herbal Liver Care is a natural supplement that both aids in hepatoprotection (protecting the liver) as well as helping the liver itself function.
  • The ingredient list includes natural items like turmeric, artichoke, long pepper, and milk thistle.\nThe Ketoveyda Herbal Kidney Care similarly looks out for the function and operation of the kidneys.

Happy Colon Foods Colonoscopy Food Kit Now Available in Kansas City, MO through Consultants in Gastroenterology, A Division of Digestive Health Specialists

Retrieved on: 
Tuesday, April 20, 2021
Clinical medicine, Medicine, Gastroenterology, Large intestine, Diagnostic gastroenterology, Cancer screening, Endoscopy, Organs, Colonoscopy, Colorectal cancer

b'KANSAS CITY, Mo., April 20, 2021 /PRNewswire-PRWeb/ -- Happy Colon Foods announces its availability in Kansas City, MO through a new, ongoing partnership with Consultants in Gastroenterology , a division of Digestive Health Specialists .

Key Points: 
  • b'KANSAS CITY, Mo., April 20, 2021 /PRNewswire-PRWeb/ -- Happy Colon Foods announces its availability in Kansas City, MO through a new, ongoing partnership with Consultants in Gastroenterology , a division of Digestive Health Specialists .
  • Happy Colon Foods is the only standardized kit of low-residue foods for use when prepping for a colonoscopy.\nHappy Colon Foods was created and developed by Board Certified Gastroenterologist, Jeff D. Scott, M.D.
  • Studies show that a low-residue diet, which is very easy for the body to process, will yield equal or better colonoscopy prep results than liquid preps.
  • "\nWith this new partnership, patients at Digestive Health Specialists will now have the opportunity to choose Happy Colon Foods when they need to prep for a colonoscopy.\nHappy Colon Foods offers the only standardized kit of low-residue foods for use when prepping for a colonoscopy.

Urovant Sciences Announces U.S. Commercial Launch of GEMTESA® (vibegron) 75 mg Tablets for Patients with Overactive Bladder

Retrieved on: 
Monday, April 12, 2021
Biotechnology, Pharmaceutical, Health, Anatomy, Urinary bladder disorders, Branches of biology, Medical specialties, Urinary system, Organs, Pelvis, Urinary bladder, Overactive bladder, Detrusor muscle, Bladder outlet obstruction, OAB

\xe2\x80\x9cThe launch of GEMTESA is a significant milestone for Urovant, as we are bringing our first product to market.

Key Points: 
  • \xe2\x80\x9cThe launch of GEMTESA is a significant milestone for Urovant, as we are bringing our first product to market.
  • GEMTESA is designed to reduce the bothersome symptoms of OAB by relaxing the detrusor bladder muscle so that the bladder can hold more urine.
  • GEMTESA may increase your chances of not being able to empty your bladder, especially if you have bladder outlet obstruction or take other medicines for treatment of overactive bladder.
  • Sumitovant is the majority shareholder of Myovant Sciences and wholly owns Urovant Sciences, Enzyvant Therapeutics, Spirovant Sciences, and Altavant Sciences.

iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication

Retrieved on: 
Saturday, April 10, 2021
Medical emergencies, Heart, Organs, Arrhythmia, Novita

On April 10, 2021, Novitas published updated reimbursement rates for codes 93243 and 93247 at $103 and $115, respectively.

Key Points: 
  • On April 10, 2021, Novitas published updated reimbursement rates for codes 93243 and 93247 at $103 and $115, respectively.
  • Investors interested in listening to the conference call may do so by accessing the live and archived webcast of the event available on the Investors section of the companys website at: www.irhythmtech.com .
  • iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed.
  • The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.